Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1

J Virol. 2000 Aug;74(15):6748-59. doi: 10.1128/jvi.74.15.6748-6759.2000.

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that persistently infects 85% of the adult population worldwide. In this report, we examine the proliferative response and cytokine secretion profile of CD4(+) T lymphocytes from a panel of unrelated EBV-positive donors against two EBV latent antigens, EBNA1 and EBNA3C. Substantial proliferative responses by CD4(+) lymphocytes were demonstrated to both antigens in multiple, randomly selected donors. Surprisingly, we observed a striking and consistent difference in cytokine response to EBNA1 and EBNA3C. EBNA1-specific CD4(+) T lymphocytes from multiple unrelated donors preferentially produced type 2-like cytokines in response to antigenic stimulation, while the response to EBNA3C was a characteristic type 1 response. The implications of these findings for EBV persistence and the development of EBV-associated malignancies are discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antigens, Viral / genetics
  • Antigens, Viral / immunology
  • Blood Donors
  • CD4-Positive T-Lymphocytes / immunology*
  • Cells, Cultured
  • Cytokines / biosynthesis*
  • Dose-Response Relationship, Drug
  • Epstein-Barr Virus Nuclear Antigens / immunology*
  • Herpesvirus 4, Human / immunology*
  • Humans
  • Infectious Mononucleosis / immunology
  • Infectious Mononucleosis / virology
  • Lymphocyte Activation
  • Recombinant Proteins / immunology
  • Recombinant Proteins / metabolism
  • Th1 Cells / immunology
  • Th2 Cells / immunology*

Substances

  • Antigens, Viral
  • Cytokines
  • Epstein-Barr Virus Nuclear Antigens
  • Recombinant Proteins